Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The function and mechanisms of action of circular RNAs in Urologic Cancer. | Mol Cancer | 2023 | 36966306 | PubTator, text mining | PubMed |
| Antidiabetic and anti-obesity properties of a polyphenol-rich flower extract from Tagetes erecta L. and its effects on Caenorhabditis elegans fat storages. | J Physiol Biochem | 2023 | 36961724 | PubTator, text mining | PubMed |
| Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection. | Front Oncol | 2023 | 36959801 | PubTator, text mining | PubMed |
| The value of artificial intelligence in the diagnosis of lung cancer: A systematic review and meta-analysis. | PLoS One | 2023 | 36952523 | PubTator, text mining | PubMed |
| Life course effects of genetic susceptibility to higher body size on body fat and lean mass: prospective cohort study. | Int J Epidemiol | 2023 | 36952292 | PubTator, text mining | PubMed |
| A novel variant affecting the cytoplasmic tail of the FAT1 protocadherin causing coloboma and renal failure: A case report. | Ophthalmic Genet | 2023 | 36951427 | PubTator, text mining | PubMed |
| Aneurysmal bone cyst: a review. | J Pathol Transl Med | 2023 | 36950810 | PubTator, text mining | PubMed |
| Biological functions, mechanisms, and clinical significance of circular RNA in colorectal cancer. | Front Oncol | 2023 | 36950552 | PubTator, text mining | PubMed |
| A strategy for the treatment of gastrointestinal cancer: Targeting tumor senescent cells. | Front Mol Biosci | 2023 | 36950520 | PubTator, text mining | PubMed |
| Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma. | Blood Adv | 2023 | 36947202 | PubTator, text mining | PubMed |
| Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors. | J Med Chem | 2023 | 36946421 | PubTator, text mining | PubMed |
| Novel Treatments Paradigms: Membranous Nephropathy. | Kidney Int Rep | 2023 | 36938069 | PubTator, text mining | PubMed |
| Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden. | Front Oncol | 2023 | 36937383 | PubTator, text mining | PubMed |
| miR-183-5p overexpression orchestrates collective invasion in salivary adenoid cystic carcinoma through the FAT1/YAP1 signaling pathway. | Biochem Biophys Res Commun | 2023 | 36934588 | PubTator, text mining | PubMed |
| A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer. | Nat Med | 2023 | 36928816 | PubTator, text mining | PubMed |
| Technical Advancements in Abdominal Diffusion-weighted Imaging. | Magn Reson Med Sci | 2023 | 36928124 | PubTator, text mining | PubMed |
| Predicting EGFR mutational status from pathology images using a real-world dataset. | Sci Rep | 2023 | 36927889 | PubTator, text mining | PubMed |
| The Hippo signaling pathway in gastric cancer. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 36924251 | PubTator, text mining | PubMed |
| Exploration of prognostic biomarkers in head and neck squamous cell carcinoma microenvironment from TCGA database. | Ann Transl Med | 2023 | 36923087 | PubTator, text mining | PubMed |
| Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 36915393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=41